Overall, the incidence of severe vascular events was similar between a selective COX-2 inhibitor and any traditional NSAID 1.0%/yr vs 0.9%/yr.
En el total, la incidencia de eventos vasculares severos fue similar entre un inhibidor selectivo de la COX-2 y cualquier AINE tradicional 1,0%/año vs 0,9%/año.
No total, a incidência de eventos vasculares graves foi similar entre um inibidor seletivo da COX-2 e qualquer AINE tradicional 1,0%/ano vs 0,9%/ano.